NCT05287256View on ClinicalTrials.gov

Comparative Pharmacokinetic and Pharmacodynamic Effects of Delta-8 and Delta-9 THC

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 23, 2022

Primary Completion Date

August 8, 2024

Study Completion Date

October 2, 2024

Conditions
Behavioral Pharmacology of Cannabis
Interventions
DRUG

Oral Delta-8-THC Cannabis

Delta-8-THC cannabis will be orally self-administered by study participants

DRUG

Oral Delta-9-THC Cannabis

Delta-9-THC cannabis will be orally self-administered by study participants

DRUG

Oral Placebo

Placebo will be orally self-administered by study participants

DRUG

Vaporized Delta-8-THC Cannabis

Delta-8-THC cannabis will be self-administered by study participants using a vaporizer

DRUG

Vaporized Delta-9-THC Cannabis

Delta-9-THC cannabis will be self-administered by study participants using a vaporizer

DRUG

Vaporized Placebo

Placebo will be self-administered by study participants using a vaporizer

Trial Locations (1)

21224

Johns Hopkins Behavioral Pharmacology Research Unit, Baltimore

All Listed Sponsors
collaborator

Substance Abuse and Mental Health Services Administration (SAMHSA)

FED

lead

Johns Hopkins University

OTHER